Speaker line-up of 2023

Bernhard Kerscher
Head of Laboratory & Preclinical Assessor, Paul-Ehrlich-Institut - German Federal Institute for Vaccines and Biomedicines

Chantal Morel
Health economist in anti-microbial resistance, KPM Center for Public Management, University of Bern

Christoph Dehio
Full Professor of Molecular Microbiology, Director of National Centre of Competence in Research (NCCR) “AntiResist”

Giancarlo Biagini
Head of the Department of Tropical Disease Biology, Liverpool School of Tropical Medicine

Jan Poolman
Vice-President, Head Bacterial Vaccine Discovery and Early Development, Janssen Vaccines & Prevention B.V.

Kevin Outterson
Austin B Fletcher Professor, Boston University, and Executive Director & Principal Investigator, CARB-X

Mark Jones, PhD PMP
Head of Development, Basilea Pharmaceutica International Ltd | BEAM Alliance - Board Member | Swiss Round Table for Antibiotics - Board Member

Morgane Vanbiervliet
Manager, Market Intelligence & Business Development, Infectious Diseases, Debiopharm International SA

Rakel Arrazuria
Researcher, Microbiology Division, Paul-Ehrlich-Institut - German Federal Institute for Vaccines and Biomedicines

Zemer Gitai
EG Conklin Professor, Department of Molecular Biology, Princeton University and Founder, ArrePath Inc.
More speaker profiles will be published soon.